What You Should Know

• Healthcare operations AI pioneer Opmed has announced the results of a multi-year collaborative study with the Mayo Clinic aimed at optimizing operating room (OR) efficiency.
• Presented at the ACC.26 (American College of Cardiology Expo), the study proves that Opmed’s multimodal deep learning platform reduces cardiovascular (CV) procedure scheduling errors by approximately 50%.
• Traditional scheduling methods rely on historic human averages, generating an inaccurate status quo Mean Absolute Error (MAE) of 1.13 hours per surgical case.
• By ingesting structured datasets alongside unstructured physician notes (Clinical + Notes), Opmed’s platform slashed that error window to a precise MAE of 0.564 hours, outperforming human clinician baselines by a factor of two.
• The platform addresses severe health system margin pressures; with idle OR time costing up to $1,000 per hour, the solution reclaims over 200 operational hours annually per room.

Why Mayo Clinic Partnered with Opmed to Standardize OR Block Metrics

The administrative and logistical infrastructure backing the nation’s high-stakes surgical suites is operating under severe post-pandemic strain. Within complex, specialized clinical environments like cardiovascular (CV) departments, planning a predictable daily operating room (OR) schedule has historically resembled an uncalibrated math problem. Because cardiac procedures are highly variable—subject to sudden anatomical anomalies, patient comorbidities, and fluid intraoperative changes—precisely predicting exactly how long a surgeon will spend inside a block is notoriously difficult.

Today, the vast majority of hospital networks continue to rely on manual spreadsheets, subjective clinician judgment, and un-adjusted historical averages to map out their suites. This lack of analytical precision generates a massive operational swing. When a procedure takes significantly longer than scheduled, it triggers a cascading delay that exhausts surgical teams, cancels subsequent operations, and drives up unmanaged incidental overtime.

Conversely, overestimating a case length leaves expensive surgical theaters completely empty. With industry data indicating that un-utilized OR blocks cost hospitals an average of $50 to $150 per minute—and roughly $1,000 in operating expenses for every unused hour—this systemic scheduling friction drains millions from a hospital’s bottom line while directly extending patient wait times.

To eliminate this data isolation and introduce a predictable system of action, healthcare operations AI leader Opmed has announced the results of a multi-year collaborative validation study with the Mayo Clinic. Presented formally before international clinical leaders at the American College of Cardiology Expo (ACC.26), the milestone dataset demonstrates that deploying multimodal deep learning models can successfully reduce cardiovascular scheduling errors by approximately 50%, opening up vital surgical capacity without adding human-capital overhead.

Decoding the Multimodal Matrix: How the Algorithm Beats the Baseline

The core technology driving the Opmed platform moves far beyond the flat, single-variable data models that limit legacy scheduling assistants. Instead of merely looking at a surgeon’s past five procedures, Opmed’s Adaptive OR Optimization Engine runs billions of predictive permutations each second. Trained on comprehensive historical case records from the Mayo Clinic spanning 2022 through 2025, the platform simultaneously ingests an array of distinct, multi-vector patient and clinical signals:

• Patient-Specific Phenotypes: Evaluates age, American Society of Anesthesiologists (ASA) physical status classification, and acute cardiac comorbidities.
• Operational Variables: Tracks specific procedure types, real-time anesthesia induction cadences, room turnover metrics, and individualized surgeon behavioral histories.
• Unstructured Text Processing: Interlaces structured medical fields with unstructured clinical data, directly parsing free-text physician notes and preoperative electrocardiogram (ECG) readouts.

To rigorously prove its predictive power, four distinct AI model configurations were tested against a completely isolated holdout cohort of 643 advanced cardiovascular procedures executed between November 2025 and January 2026. The baseline human estimation method recorded a volatile Mean Absolute Error (MAE) of 1.13 hours.

By contrast, Opmed’s top-performing configuration—which combined structured clinical fields with unstructured pre-op dictations (Clinical + Notes)—achieved a historic MAE of just 0.564 hours, a root mean square error (RMSE) of 0.799 hours, and a predictive variance ($R^2$) score of 0.721. This dwarfs the blunted 0.31 $R^2$ baseline scored by human scheduling teams. Across every single model variation evaluated by the Mayo Clinic, the platform consistently held its prediction error under 0.60 hours, establishing an unassailable data standard that human scheduling intuition cannot replicate.

The Financial Return

The immediate economic impact of this operational precision addresses the primary margin challenges keeping health system executives up at night. Operating rooms serve as a hospital’s primary financial engine, frequently generating upwards of 40% of total corporate expenses and a dominant share of net revenue. By tightly aligning predicted schedules with actual, physical procedural times, the platform effectively eliminates artificial bottlenecks, allows departments to confidently schedule an additional two to three complex cases per month, and reclaims over 200 wasted OR hours annually per room.

“While much of the healthcare AI conversation focuses on areas such as medical imaging or surgical tools when it comes to AI’s impact, this study demonstrates the potential, to patients and medical centers alike, of AI scheduling,” stated Dr. Mor Brokman Meltzer, CEO and Co-founder of Opmed. “Being able to collaborate with the Mayo Clinic to study this impact over a long period serves as a major milestone in bringing this technology and its impact to the forefront of the medical AI conversation.”